Search

everythinglearnresearchcommunity

for

Search:↓

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Scalp skin barrier affects hair loss; personalized treatments needed.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Minoxidil doesn't affect perifollicular lymphoid infiltration in alopecia areata patients.

People with alopecia areata often have lower vitamin D levels, which are linked to more severe and longer-lasting hair loss, but vitamin D receptor levels in the skin don't show the same pattern and don't predict treatment success.

Apremilast did not work for treating severe alopecia areata.

The study concluded that yellow dots are a common and useful sign for diagnosing alopecia areata in dark-skinned individuals and may indicate the severity of the condition.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

Some treatments can help hair regrowth in alopecia areata, but none offer a cure, and effectiveness varies.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Higher CRBP1 levels are linked to more severe alopecia areata.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

People with alopecia areata have higher levels of osteopontin, which might be important in the disease's development, but this doesn't relate to how severe the disease is.

Red laser therapy helped regrow hair in an alopecia areata patient within 21 days.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Mice with alopecia areata had wider lymphatic vessels in their skin.

High-resolution MRI can distinguish between tertiary androgenetic alopecia and severe alopecia areata by measuring scalp and tissue thickness and hair follicle depth.

Alopecia is not a significant predictor of thyroid disease when age and sex are considered.

The C3H/HeJ mouse model is useful for studying and testing treatments for alopecia areata.

Bimatoprost and clobetasol are both effective for scalp hair loss, but bimatoprost works faster, has fewer side effects, and grows more colored hair.

Hair loss can be treated with medications like minoxidil and finasteride or surgery, but treatment effectiveness varies by alopecia type and accurate diagnosis is important.

The review concludes that accurate diagnosis of different types of hair loss requires proper biopsy techniques and understanding the hair growth cycle and underlying causes.

Early high-dose steroid treatment helps prolong disease-free periods in severe alopecia areata.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

Higher CD70 and CD27 gene expression in alopecia areata lesions predicts disease severity and activity.

Hypothyroidism may cause certain types of hair loss.

Blocking the protein CXCL12 with a specific antibody can increase hair growth in common hair loss conditions.